TrialThe New England journal of medicine2017
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis.
Philip Mease et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
276 papers cite itlatest 60 shown
this paperpooled ittrialcites it